From obesity to cancer: Gut microbiome mechanisms, biomarkers, and U.S. public health strategies

The gut microbiome functions as both a biomarker and therapeutic target across metabolic and neoplastic diseases. Integrating microbiome science with environmental epidemiology and MPE frameworks offers transformative potential for precision prevention and equitable public health strategies in the U.S.